热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　百济神州（06160）早盘股价上涨6.08%，现报209.40港元，成交额7.25亿港元。

　　百济神州此前发布业绩，第三季度营收首破百亿元，达100.77亿元，同比增长41.1%。与此同时，公司营业利润达7.46亿元，归母净利润为6.89亿元，归母扣非净利润为7.08亿元。业绩增长主要得益于BTK抑制剂百悦泽（泽布替尼）、PD-1抑制剂百泽安（替雷利珠单抗）延续了高速放量态势，并叠加安进授权产品的销售增长。

　　交银国际发布研报称，百济神州第三季度产品收入14.1亿美元，同比增长41%。基于今年第三季度业绩上调公司净利润预测3%至52%，主要反映对经营费用率更乐观的预期。海通国际则表示，考虑到百济神州泽布替尼在美国及欧洲市场的放量超该行预期，故上调其2025-2027年收入预期至53亿/64亿/71亿美元，对应年均复合成长率为23%。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.